Samantha Brandler

Title: Samantha Brandler: Innovator in Viral Research

Introduction

Samantha Brandler is a notable inventor based in Bouguenais, France. She has made significant contributions to the field of viral research, particularly in the development of innovative vaccine formulations.

Latest Patents

Samantha Brandler holds a patent for her invention titled "Recombinant measles virus expressing chikungunya virus polypeptides and their applications." This invention relates to recombinant measles virus that expresses chikungunya virus polypeptides. It specifically concerns virus-like particles (VLP) that contain envelope and capsid proteins of the chikungunya virus on their surface. These particles are recombinant infectious particles capable of replicating in a host after administration. The invention provides various means, including nucleic acids, vectors, cells, and rescue systems, to produce these recombinant infectious particles. Additionally, it relates to the use of these particles, particularly in vaccine formulations, for the treatment or prevention of chikungunya virus infections.

Career Highlights

Throughout her career, Samantha has worked with prestigious organizations, including Institut Pasteur and Themis Bioscience GmbH. Her work has focused on advancing the understanding and treatment of viral infections.

Collaborations

Samantha has collaborated with notable colleagues in her field, including Frederic Tangy and Philippe Despres. Their joint efforts have contributed to the advancement of viral research and vaccine development.

Conclusion

Samantha Brandler's innovative work in viral research and her patent for recombinant measles virus demonstrate her commitment to advancing medical science. Her contributions are vital in the ongoing fight against viral infections.